Erfe - publications

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias

Annelies J van Vuren, Alaa Sharfo, Simon T Grootendorst, Stephanie van Straaten, Arjen M Punt, Jesper B Petersen, Daniel El Fassi.  Hemasphere. 2021 Aug 11;5(9):e627. doi: 10.1097/HS9.0000000000000627. eCollection 2021 Sep. https://pubmed.ncbi.nlm.nih.gov/34396049/

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study.

Belinda Spoto, Rahul Kakkar, Larry Lo, Matt Devalaraja, Patrizia Pizzini, Claudia Torino, Daniela Leonardis, Sebastiano Cutrupi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali. J Clin Med. 2019 8(4): 523. https://pubmed.ncbi.nlm.nih.gov/30995819/

Analytical and Biological Assessment of Circulating Human Erythroferrone.

Sarah Appleby, Janice Chew-Harris, Richard W. Troughton, A. Mark Richards, Christopher J. Pemberton. 2020. Clin Biochem 79: 41-47. https://pubmed.ncbi.nlm.nih.gov/32032568/

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

João Arezes, Niall Foy, Kirsty McHugh, Doris Quinkert, Susan Benard, Anagha Sawant, Blood. 2020 Feb 20;135(8):547-557
https://ashpublications.org/blood/article/135/8/547/430059/Antibodies-against-the-erythroferrone-N-terminal

Erythroferrone as a sensitive biomarker to detect stimulationof erythropoiesis.

Kelvin Ramirez Cuevas, Céline Schobinger, Emeric Gottardo, Sven Christian Voss, Tiia Kuuranne, Jean-Daniel Tissot, Bernard Favrat, Nathan Townsend, Nicolas Leuenberger. Drug Test Anal. 2019; 1-7